Cargando…

Targeting Histamine Receptors in Irritable Bowel Syndrome: A Critical Appraisal

Irritable bowel syndrome is a group of functional gastrointestinal disorders with not yet fully clarified etiology. Recent evidence suggesting that mast cells may play a central role in the pathogenesis of irritable bowel syndrome paves the way for agents targeting histamine receptors as a potential...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fabisiak, Adam, Włodarczyk, Jakub, Fabisiak, Natalia, Storr, Martin, Fichna, Jakub
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Neurogastroenterology and Motility 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5503283/ https://www.ncbi.nlm.nih.gov/pubmed/28551943 http://dx.doi.org/10.5056/jnm16203

Ejemplares similares

Clinical potential of eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome
por: Sobolewska-Włodarczyk, Aleksandra, et al.
Publicado: (2016)

Desensitization of transient receptor potential vanilloid type-1 (TRPV1) channel as promising therapy of irritable bowel syndrome: characterization of the action of palvanil in the mouse gastrointestinal tract
por: Szymaszkiewicz, Agata, et al.
Publicado: (2020)

Anti-inflammatory and antibacterial effects of human cathelicidin active fragment KR-12 in the mouse models of colitis: a novel potential therapy of inflammatory bowel diseases
por: Fabisiak, Natalia, et al.
Publicado: (2020)

Activation of Free Fatty Acid Receptor 4 Affects Intestinal Inflammation and Improves Colon Permeability in Mice
por: Salaga, Maciej, et al.
Publicado: (2021)

Focus on current and future management possibilities in inflammatory bowel disease-related chronic pain
por: Zielińska, Anna, et al.
Publicado: (2018)

Future Treatment of Constipation-associated Disorders: Role of Relamorelin and Other Ghrelin Receptor Agonists
por: Mosińska, Paula, et al.
Publicado: (2017)

Characterization of the Synergistic Effect between Ligands of Opioid and Free Fatty Acid Receptors in the Mouse Model of Colitis
por: Binienda, Agata, et al.
Publicado: (2021)

Brain-Gut Interactions in IBS
por: Fichna, Jakub, et al.
Publicado: (2012)

A Crosstalk between the Cannabinoid Receptors and Nociceptin Receptors in Colitis—Clinical Implications
por: Wołyniak, Maria, et al.
Publicado: (2022)

Physiology, signaling, and pharmacology of opioid receptors and their ligands in the gastrointestinal tract: current concepts and future perspectives
por: Sobczak, Marta, et al.
Publicado: (2013)

Critical Appraisal of “Association between Diet and Lifestyle Habits and Irritable Bowel Syndrome: A Case-Control Study”
por: Noseworthy, Samantha
Publicado: (2017)

Organometallic Compounds and Metal Complexes in Current and Future Treatments of Inflammatory Bowel Disease and Colorectal Cancer—a Critical Review
por: Szczepaniak, Adrian, et al.
Publicado: (2019)

Oxidative Stress Does Not Influence Subjective Pain Sensation in Inflammatory Bowel Disease Patients
por: Zielińska, Anna Krystyna, et al.
Publicado: (2021)

The association of the quality of sleep with proinflammatory cytokine profile in inflammatory bowel disease patients
por: Sobolewska-Włodarczyk, Aleksandra, et al.
Publicado: (2021)

Desperately seeking a cure: Treatment seeking and appraisal in irritable bowel syndrome
por: Harvey, J. Matthew, et al.
Publicado: (2018)

Irritable bowel syndrome: Is it “irritable brain” or “irritable bowel”?
por: Padhy, Susanta Kumar, et al.
Publicado: (2015)

Berberine Improves Intestinal Motility and Visceral Pain in the Mouse Models Mimicking Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) Symptoms in an Opioid-Receptor Dependent Manner
por: Chen, Chunqiu, et al.
Publicado: (2015)

Short-chain fatty acids–microbiota crosstalk in the coronavirus disease (COVID-19)
por: Włodarczyk, Jakub, et al.
Publicado: (2022)

Relationship between cognitive appraisals of symptoms and negative mood for subtypes of irritable bowel syndrome
por: Sugaya, Nagisa, et al.
Publicado: (2008)

Current Overview on Clinical Management of Chronic Constipation
por: Włodarczyk, Jakub, et al.
Publicado: (2021)

Current Overview on the Use of Mesenchymal Stem Cells for Perianal Fistula Treatment in Patients with Crohn’s Disease
por: Włodarczyk, Marcin, et al.
Publicado: (2021)

A rare variant of ileus – Bouveret’s syndrome
por: Frąk, Weronika, et al.
Publicado: (2022)

Protease-Activated Receptors – Key Regulators of Inflammatory Bowel Diseases Progression
por: Jacenik, Damian, et al.
Publicado: (2021)

IBS-Symptoms in IBD Patients—Manifestation of Concomitant or Different Entities
por: Szałwińska, Patrycja, et al.
Publicado: (2020)

Probiotic Therapy of the Irritable Bowel Syndrome: Why Is the Evidence Still Poor and What Can Be Done About It?
por: Mazurak, Nazar, et al.
Publicado: (2015)

Dose rate measurement of a cobalt source 'Issledovatel' by means of Fricke dosimeter
por: Peimel-Stuglik, Z, et al.
Publicado: (2001)

Alanine-EPR dosimetry for measurements of ionizing radiation absorbed doses in the range 0.5-10 kGy
por: Peimel-Stuglik, Z, et al.
Publicado: (2001)

Crosstalk between neuroinflammation and oxidative stress in epilepsy
por: Fabisiak, Timothy, et al.
Publicado: (2022)

Current concepts in the pathogenesis of cryptoglandular perianal fistula
por: Włodarczyk, Marcin, et al.
Publicado: (2021)

Irritable Bowel Syndrome
por: Farup, Per G., et al.
Publicado: (2012)

The Hydrogenation Impact on Electronic Properties of p-Diamond/n-Si Heterojunctions
por: Łoś, Szymon, et al.
Publicado: (2021)

Blockade of fructose transporter protein GLUT5 inhibits proliferation of colon cancer cells: proof of concept for a new class of anti-tumor therapeutics
por: Włodarczyk, Jakub, et al.
Publicado: (2021)

Melatonin, but not melatonin receptor agonists Neu-P11 and Neu-P67, attenuates TNBS-induced colitis in mice
por: Zielińska, Marta, et al.
Publicado: (2016)

Calea zacatechichi dichloromethane extract exhibits antidiarrheal and antinociceptive effects in mouse models mimicking irritable bowel syndrome
por: Sałaga, M., et al.
Publicado: (2015)

The Role of Chronic Fatigue in Patients with Crohn’s Disease
por: Włodarczyk, Marcin, et al.
Publicado: (2023)

Serotonin receptor modulators in the treatment of irritable bowel syndrome
por: Fayyaz, Mohammad, et al.
Publicado: (2008)

Review article: the role of oxidative stress in pathogenesis and treatment of inflammatory bowel diseases
por: Piechota-Polanczyk, Aleksandra, et al.
Publicado: (2014)

Supplementation of Bovine Colostrum in Inflammatory Bowel Disease: Benefits and Contraindications
por: Sienkiewicz, Michał, et al.
Publicado: (2020)

Expression of FFAR3 and FFAR4 Is Increased in Gastroesophageal Reflux Disease
por: Fabisiak, Adam, et al.
Publicado: (2020)

Targeted therapies for diarrhea-predominant irritable bowel syndrome
por: Olden, Kevin W
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_gsdhas62gf2op0v2gvg8khbhej